Last week, the CDC released an advisory regarding severe cases of parechovirus in young infants. Parechovirus is a common virus: most children have had it by the time they are five years old. Children with the virus often ...
Aug 1, 2022
0
3
Florida is facing several disease outbreaks—COVID, monkeypox, dengue fever. But meningococcal disease is now on the minds of health experts, too.
Jul 25, 2022
0
71
Stroke surgery and other neuroendovascular procedures could be made safer and easier through robotics, according to research presented today at the Society of NeuroInterventional Surgery's (SNIS) 19th Annual Meeting. A new ...
Jul 25, 2022
0
9
Currently, the only accurate diagnosis of Alzheimer's disease is through postmortem analyses after a patient dies, but investigators have now developed a highly sensitive method for quantifying levels of tau protein—a hallmark ...
Jul 21, 2022
0
13
Spinal cord and brain injury researchers at Indiana University School of Medicine are studying new alternatives to promote functional recovery after a spinal cord injury.
Jul 19, 2022
0
15
Multiple sclerosis (MS), a chronic neurological disease of the brain and spinal cord, is the most common neurologic disease occurring in young people. In fact, this disease impacts approximately a quarter of a million Americans.
Jul 18, 2022
0
6
Antisense oligonucleotides, or ASOs, are molecules that can be used to control protein levels in cells. Cold Spring Harbor Laboratory Professor Adrian Krainer leveraged ASO technology to develop the first FDA-approved treatment ...
Jul 14, 2022
0
73
In a Johns Hopkins Medicine study of patients who underwent adult spinal deformity (ASD) surgery, pre-operative opioid use and pain duration of four or more years were independently associated with higher odds of chronic ...
Jul 13, 2022
0
4
In 2016, Spinraza became a game-changer for spinal muscular atrophy (SMA) patients. It was the first FDA-approved treatment for the neurodegenerative disease, which is the leading genetic cause of infant death. The drug ...
Jul 13, 2022
0
48
Scientists from the University of Birmingham have shown that a brain-penetrating candidate drug currently in development as a cancer therapy can foster regeneration of damaged nerves after spinal trauma.
Jul 12, 2022
0
2019
